1
|
Pei G, Balkema-Buschmann A, Dorhoi A. Disease tolerance as immune defense strategy in bats: One size fits all? PLoS Pathog 2024; 20:e1012471. [PMID: 39236038 PMCID: PMC11376593 DOI: 10.1371/journal.ppat.1012471] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/07/2024] Open
Abstract
Bats are natural reservoirs for zoonotic pathogens, yet the determinants of microbial persistence as well as the specific functionality of their immune system remain largely enigmatic. Their propensity to harbor viruses lethal to humans and/or livestock, mostly in absence of clinical disease, makes bats stand out among mammals. Defending against pathogens relies on avoidance, resistance, and/or tolerance strategies. In bats, disease tolerance has recently gained increasing attention as a prevailing host defense paradigm. We here summarize the current knowledge on immune responses in bats in the context of infection with zoonotic agents and discuss concepts related to disease tolerance. Acknowledging the wide diversity of bats, the broad spectrum of bat-associated microbial species, and immune-related knowledge gaps, we identify research priorities necessary to provide evidence-based proofs for disease tolerance in bats. Since disease tolerance relies on networks of biological processes, we emphasize that investigations beyond the immune system, using novel technologies and computational biology, could jointly advance our knowledge about mechanisms conferring bats reservoir abilities. Although disease tolerance may not be the "one fit all" defense strategy, deciphering disease tolerance in bats could translate into novel therapies and inform prevention of spillover infections to humans and livestock.
Collapse
Affiliation(s)
- Gang Pei
- Institute of Immunology, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald-Insel Riems, Germany
| | - Anne Balkema-Buschmann
- Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Federal Research Institute of Animal Health, Greifswald-Insel Riems, Germany
| | - Anca Dorhoi
- Institute of Immunology, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald-Insel Riems, Germany
- Faculty of Mathematics and Natural Sciences, University of Greifswald, Greifswald, Germany
| |
Collapse
|
2
|
Common Themes in Zoonotic Spillover and Disease Emergence: Lessons Learned from Bat- and Rodent-Borne RNA Viruses. Viruses 2021; 13:v13081509. [PMID: 34452374 PMCID: PMC8402684 DOI: 10.3390/v13081509] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2021] [Revised: 07/22/2021] [Accepted: 07/28/2021] [Indexed: 12/18/2022] Open
Abstract
Rodents (order Rodentia), followed by bats (order Chiroptera), comprise the largest percentage of living mammals on earth. Thus, it is not surprising that these two orders account for many of the reservoirs of the zoonotic RNA viruses discovered to date. The spillover of these viruses from wildlife to human do not typically result in pandemics but rather geographically confined outbreaks of human infection and disease. While limited geographically, these viruses cause thousands of cases of human disease each year. In this review, we focus on three questions regarding zoonotic viruses that originate in bats and rodents. First, what biological strategies have evolved that allow RNA viruses to reside in bats and rodents? Second, what are the environmental and ecological causes that drive viral spillover? Third, how does virus spillover occur from bats and rodents to humans?
Collapse
|
3
|
Lojkić I, Šimić I, Bedeković T, Krešić N. Current Status of Rabies and Its Eradication in Eastern and Southeastern Europe. Pathogens 2021; 10:pathogens10060742. [PMID: 34204652 PMCID: PMC8231232 DOI: 10.3390/pathogens10060742] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2021] [Revised: 05/27/2021] [Accepted: 06/09/2021] [Indexed: 11/16/2022] Open
Abstract
The objective of this paper is to provide an overview of the current status of rabies in Europe, with special emphasis on Croatia and Southeast and East Europe. Due to the systematic implementation of a rabies eradication program by oral vaccination of wild animals, by the end of the 20th century, most West and Central European countries were rabies-free. The EU goal was to eradicate rabies in wildlife and domestic animals by 2020. No matter how achievable the goal seemed to be, the disease is still present in the eastern part of the EU, as was notified in 2020 by two member states—Poland and Romania. Croatia has been rabies-free for the last seven years but given that it borders a non-EU country in which a case of rabies was confirmed in 2020, it will continue to contribute to the maintenance of the rabies-free region. A rabies-free EU can only be achieved by continuous oral vaccination, coordination and a regional approach. The prevention of reintroductions from bordering countries in which rabies has not been eradicated yet, and the support for the eradication efforts made by these countries, are goals still pending.
Collapse
Affiliation(s)
- Ivana Lojkić
- Laboratory for Rabies and General Virology, Department of Virology, Croatian Veterinary Institute, 10000 Zagreb, Croatia; (T.B.); (N.K.)
- Correspondence:
| | - Ivana Šimić
- Laboratory for Molecular Virology, Division of Molecular Medicine, Ruđer Bošković Institute, 10000 Zagreb, Croatia;
| | - Tomislav Bedeković
- Laboratory for Rabies and General Virology, Department of Virology, Croatian Veterinary Institute, 10000 Zagreb, Croatia; (T.B.); (N.K.)
| | - Nina Krešić
- Laboratory for Rabies and General Virology, Department of Virology, Croatian Veterinary Institute, 10000 Zagreb, Croatia; (T.B.); (N.K.)
| |
Collapse
|
4
|
Begeman L, Suu-Ire R, Banyard AC, Drosten C, Eggerbauer E, Freuling CM, Gibson L, Goharriz H, Horton DL, Jennings D, Marston DA, Ntiamoa-Baidu Y, Riesle Sbarbaro S, Selden D, Wise EL, Kuiken T, Fooks AR, Müller T, Wood JLN, Cunningham AA. Experimental Lagos bat virus infection in straw-colored fruit bats: A suitable model for bat rabies in a natural reservoir species. PLoS Negl Trop Dis 2020; 14:e0008898. [PMID: 33320860 PMCID: PMC7771871 DOI: 10.1371/journal.pntd.0008898] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2020] [Revised: 12/29/2020] [Accepted: 10/19/2020] [Indexed: 12/12/2022] Open
Abstract
Rabies is a fatal neurologic disease caused by lyssavirus infection. Bats are important natural reservoir hosts of various lyssaviruses that can be transmitted to people. The epidemiology and pathogenesis of rabies in bats are poorly understood, making it difficult to prevent zoonotic transmission. To further our understanding of lyssavirus pathogenesis in a natural bat host, an experimental model using straw-colored fruit bats (Eidolon helvum) and Lagos bat virus, an endemic lyssavirus in this species, was developed. To determine the lowest viral dose resulting in 100% productive infection, bats in five groups (four bats per group) were inoculated intramuscularly with one of five doses, ranging from 100.1 to 104.1 median tissue culture infectious dose (TCID50). More bats died due to the development of rabies after the middle dose (102.1 TCID50, 4/4 bats) than after lower (101.1, 2/4; 101.1, 2/4) or higher (103.1, 2/4; 104.1, 2/4) doses of virus. In the two highest dose groups, 4/8 bats developed rabies. Of those bats that remained healthy 3/4 bats seroconverted, suggesting that high antigen loads can trigger a strong immune response that abrogates a productive infection. In contrast, in the two lowest dose groups, 3/8 bats developed rabies, 1/8 remained healthy and seroconverted and 4/8 bats remained healthy and did not seroconvert, suggesting these doses are too low to reliably induce infection. The main lesion in all clinically affected bats was meningoencephalitis associated with lyssavirus-positive neurons. Lyssavirus antigen was detected in tongue epithelium (5/11 infected bats) rather than in salivary gland epithelium (0/11), suggesting viral excretion via the tongue. Thus, intramuscular inoculation of 102.1 TCID50 of Lagos bat virus into straw-colored fruit bats is a suitable model for lyssavirus associated bat rabies in a natural reservoir host, and can help with the investigation of lyssavirus infection dynamics in bats.
Collapse
Affiliation(s)
- Lineke Begeman
- Department of Viroscience, Erasmus University Medical Centre, Rotterdam, The Netherlands
- * E-mail: (LB); (AAC)
| | - Richard Suu-Ire
- School of Veterinary Medicine, College of Basic and Applied Sciences, University of Ghana, Accra, Ghana
- Institute of Zoology, Zoological Society of London, Regent’s Park, London, United Kingdom
| | - Ashley C. Banyard
- Wildlife Zoonoses and Vector Borne Disease Research Group, Animal and Plant Health Agency, Addlestone, United Kingdom
| | - Christian Drosten
- Institute of Virology, Medical University of Berlin, Berlin, Germany
| | - Elisa Eggerbauer
- Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald, Island of Riems, Germany
- Thüringer Landesamt für Verbraucherschutz, Bad Langensalza, Thüringen, Germany
| | - Conrad M. Freuling
- Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald, Island of Riems, Germany
| | - Louise Gibson
- Institute of Zoology, Zoological Society of London, Regent’s Park, London, United Kingdom
| | - Hooman Goharriz
- Wildlife Zoonoses and Vector Borne Disease Research Group, Animal and Plant Health Agency, Addlestone, United Kingdom
| | - Daniel L. Horton
- School of Veterinary Medicine, University of Surrey, Guildford, United Kingdom
| | - Daisy Jennings
- Wildlife Zoonoses and Vector Borne Disease Research Group, Animal and Plant Health Agency, Addlestone, United Kingdom
| | - Denise A. Marston
- Wildlife Zoonoses and Vector Borne Disease Research Group, Animal and Plant Health Agency, Addlestone, United Kingdom
| | - Yaa Ntiamoa-Baidu
- Centre for African Wetlands / Department of Animal Biology and Conservation Science, University of Ghana, Accra, Ghana
| | - Silke Riesle Sbarbaro
- Institute of Zoology, Zoological Society of London, Regent’s Park, London, United Kingdom
- University of Cambridge, Cambridge, United Kingdom
| | - David Selden
- Wildlife Zoonoses and Vector Borne Disease Research Group, Animal and Plant Health Agency, Addlestone, United Kingdom
| | - Emma L. Wise
- Wildlife Zoonoses and Vector Borne Disease Research Group, Animal and Plant Health Agency, Addlestone, United Kingdom
| | - Thijs Kuiken
- Department of Viroscience, Erasmus University Medical Centre, Rotterdam, The Netherlands
| | - Anthony R. Fooks
- Wildlife Zoonoses and Vector Borne Disease Research Group, Animal and Plant Health Agency, Addlestone, United Kingdom
| | - Thomas Müller
- Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald, Island of Riems, Germany
| | | | - Andrew A. Cunningham
- Institute of Zoology, Zoological Society of London, Regent’s Park, London, United Kingdom
- * E-mail: (LB); (AAC)
| |
Collapse
|
5
|
Suu-Ire R, Begeman L, Banyard AC, Breed AC, Drosten C, Eggerbauer E, Freuling CM, Gibson L, Goharriz H, Horton DL, Jennings D, Kuzmin IV, Marston D, Ntiamoa-Baidu Y, Riesle Sbarbaro S, Selden D, Wise EL, Kuiken T, Fooks AR, Müller T, Wood JLN, Cunningham AA. Pathogenesis of bat rabies in a natural reservoir: Comparative susceptibility of the straw-colored fruit bat (Eidolon helvum) to three strains of Lagos bat virus. PLoS Negl Trop Dis 2018; 12:e0006311. [PMID: 29505617 PMCID: PMC5854431 DOI: 10.1371/journal.pntd.0006311] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2017] [Revised: 03/15/2018] [Accepted: 02/10/2018] [Indexed: 12/25/2022] Open
Abstract
Rabies is a fatal neurologic disease caused by lyssavirus infection. People are infected through contact with infected animals. The relative increase of human rabies acquired from bats calls for a better understanding of lyssavirus infections in their natural hosts. So far, there is no experimental model that mimics natural lyssavirus infection in the reservoir bat species. Lagos bat virus is a lyssavirus that is endemic in straw-colored fruit bats (Eidolon helvum) in Africa. Here we compared the susceptibility of these bats to three strains of Lagos bat virus (from Senegal, Nigeria, and Ghana) by intracranial inoculation. To allow comparison between strains, we ensured the same titer of virus was inoculated in the same location of the brain of each bat. All bats (n = 3 per strain) were infected, and developed neurological signs, and fatal meningoencephalitis with lyssavirus antigen expression in neurons. There were three main differences among the groups. First, time to death was substantially shorter in the Senegal and Ghana groups (4 to 6 days) than in the Nigeria group (8 days). Second, each virus strain produced a distinct clinical syndrome. Third, the spread of virus to peripheral tissues, tested by hemi-nested reverse transcriptase PCR, was frequent (3 of 3 bats) and widespread (8 to 10 tissues positive of 11 tissues examined) in the Ghana group, was frequent and less widespread in the Senegal group (3/3 bats, 3 to 6 tissues positive), and was rare and restricted in the Nigeria group (1/3 bats, 2 tissues positive). Centrifugal spread of virus from brain to tissue of excretion in the oral cavity is required to enable lyssavirus transmission. Therefore, the Senegal and Ghana strains seem most suitable for further pathogenesis, and for transmission, studies in the straw-colored fruit bat. Rabies is a neurologic disease that causes severe suffering and is almost always fatal. The disease is caused by infection with a virus of the genus Lyssavirus, of which 16 species are known. These viruses replicate in neurons, are excreted in the mouth, and are transmitted by bites. Dogs are the most important source of rabies for humans, but recently there is a relative increase in people contracting the disease from bats. To better understand the development of human rabies caused by these bat-acquired viruses, we need to study this disease in its bat host under controlled circumstances. To do so, we chose a naturally occurring lyssavirus–host combination: Lagos bat virus in straw-colored fruit bats. We compared three available strains of Lagos bat virus (all isolated from brains of this bat species) for their ability to mimic a natural infection. We used intracranial inoculation to ensure infection of the brain. All three strains infected brain neurons, resulting in fatal neurologic disease, however only two of the strains showed the ability to reach the site of excretion—the mouth—and were considered a suitable virus to use for further studies of this disease in bats.
Collapse
Affiliation(s)
- Richard Suu-Ire
- Institute of Zoology, Zoological Society of London, London, United Kingdom
- Department of Animal Biology and Conservation Science, University of Ghana, Accra, Ghana
- Veterinary Services Department, Ministry of Food and Agriculture, Accra, Ghana
- Wildlife Division of the Forestry Commission, Accra, Ghana
| | - Lineke Begeman
- Department of Viroscience, Erasmus University Medical Centre, Rotterdam, The Netherlands
| | - Ashley C. Banyard
- Wildlife Zoonoses and Vector Borne Disease Research Group, Animal and Plant Health Agency, Addlestone, United Kingdom
| | - Andrew C. Breed
- Wildlife Zoonoses and Vector Borne Disease Research Group, Animal and Plant Health Agency, Addlestone, United Kingdom
| | - Christian Drosten
- Institute of Virology, Medical University of Berlin, Berlin, Germany
| | - Elisa Eggerbauer
- Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald, Island of Riems, Germany
| | - Conrad M. Freuling
- Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald, Island of Riems, Germany
| | - Louise Gibson
- Institute of Zoology, Zoological Society of London, London, United Kingdom
| | - Hooman Goharriz
- Wildlife Zoonoses and Vector Borne Disease Research Group, Animal and Plant Health Agency, Addlestone, United Kingdom
| | - Daniel L. Horton
- School of Veterinary Medicine, University of Surrey, Guildford, United Kingdom
| | - Daisy Jennings
- Wildlife Zoonoses and Vector Borne Disease Research Group, Animal and Plant Health Agency, Addlestone, United Kingdom
| | - Ivan V. Kuzmin
- Department of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America
| | - Denise Marston
- Wildlife Zoonoses and Vector Borne Disease Research Group, Animal and Plant Health Agency, Addlestone, United Kingdom
| | - Yaa Ntiamoa-Baidu
- Department of Animal Biology and Conservation Science, University of Ghana, Accra, Ghana
| | - Silke Riesle Sbarbaro
- Institute of Zoology, Zoological Society of London, London, United Kingdom
- Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom
| | - David Selden
- Wildlife Zoonoses and Vector Borne Disease Research Group, Animal and Plant Health Agency, Addlestone, United Kingdom
| | - Emma L. Wise
- Wildlife Zoonoses and Vector Borne Disease Research Group, Animal and Plant Health Agency, Addlestone, United Kingdom
| | - Thijs Kuiken
- Department of Viroscience, Erasmus University Medical Centre, Rotterdam, The Netherlands
| | - Anthony R. Fooks
- Wildlife Zoonoses and Vector Borne Disease Research Group, Animal and Plant Health Agency, Addlestone, United Kingdom
| | - Thomas Müller
- Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald, Island of Riems, Germany
| | - James L. N. Wood
- Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom
| | - Andrew A. Cunningham
- Institute of Zoology, Zoological Society of London, London, United Kingdom
- * E-mail:
| |
Collapse
|
6
|
Qin Y, Smith TG, Jackson F, Gallardo-Romero NF, Morgan CN, Olson V, Hutson CL, Wu X. Revisiting rabies virus neutralizing antibodies through infecting BALB/c mice with live rabies virus. Virus Res 2018; 248:39-43. [PMID: 29471052 DOI: 10.1016/j.virusres.2018.02.012] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2017] [Revised: 02/02/2018] [Accepted: 02/12/2018] [Indexed: 12/24/2022]
Abstract
This study investigates the production of rabies virus (RABV) neutralizing antibody after virus infection through a mouse model. The BALB/c mice from different age groups (three, five, seven week old) were intramuscularly inoculated with live rabies virus (TX coyote 323R). Without pre-exposure or post-exposure prophylaxis (PEP), we found there is a decreased fatality with increased age of animals, the mortalities are 60%, 50%, and 30%, respectively. Interestingly, through assay of rapid fluorescent focus inhibition test (RFFIT), direct fluorescent antibody (DFA) and quantitative Polymerase Chain Reaction (qPCR), the results showed that all the animals that succumbed to rabies challenge, except one, developed circulating neutralizing antibodies, and all the healthy animals, except two, did not generate virus neutralizing antibodies (VNA). Our animal study suggests that the induction of VNA was an indicator of infection progression in the central nervous system (CNS) and speculate that RABV neutralizing antibodies did not cross the blood-brain barrier of the CNS for those diseased animals. We hypothesize that early release of viral antigens from damaged nerve tissue might potentially be a benefit for survivors, and we also discuss several other aspects of the interaction of RABV and its neutralizing antibodies.
Collapse
Affiliation(s)
- Yunlong Qin
- Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30329, USA; Chronic Viral Diseases Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30329, USA.
| | - Todd G Smith
- Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30329, USA
| | - Felix Jackson
- Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30329, USA
| | - Nadia F Gallardo-Romero
- Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30329, USA
| | - Clint N Morgan
- Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30329, USA
| | - Victoria Olson
- Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30329, USA
| | - Christina L Hutson
- Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30329, USA.
| | - Xianfu Wu
- Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30329, USA
| |
Collapse
|
7
|
Healy DM, Brookes SM, Banyard AC, Núñez A, Cosby SL, Fooks AR. Pathobiology of rabies virus and the European bat lyssaviruses in experimentally infected mice. Virus Res 2012; 172:46-53. [PMID: 23274107 DOI: 10.1016/j.virusres.2012.12.011] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2012] [Revised: 12/15/2012] [Accepted: 12/18/2012] [Indexed: 12/25/2022]
Abstract
A comparison of the clinicopathology of European bat lyssavirus (EBLV) types-1 and -2 and of rabies virus was undertaken. Following inoculation of mice at a peripheral site with these viruses, clinical signs of rabies and distribution of virus antigen in the mouse brain were examined. The appearance of clinical signs of disease varied both within and across the different virus species, with variation in incubation periods and weight loss throughout disease progression. The distribution of viral antigen throughout the regions of the brain examined was similar for each of the isolates during the different stages of disease progression, suggesting that antigen distribution was not associated with clinical presentation. However, specific regions of the brain including the cerebellum, caudal medulla, hypothalamus and thalamus, showed notable differences in the proportion of virus antigen positive cells present in comparison to other brain regions suggesting that these areas are important in disease development irrespective of virus species.
Collapse
Affiliation(s)
- D M Healy
- Wildlife Zoonoses and Vector-borne Diseases Research Group (WZ&VBDRG), Department of Virology, Animal Health and Veterinary Laboratories Agency (AHVLA), Woodham Lane, New Haw, Addlestone, Surrey, KT15 3NB, United Kingdom.
| | | | | | | | | | | |
Collapse
|
8
|
Boni R, Rabitti PG. Tiroidite di De Quervain: concetti attuali e nostra casistica. ITALIAN JOURNAL OF MEDICINE 2011. [DOI: 10.1016/j.itjm.2010.07.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
9
|
Repeated detection of European bat lyssavirus type 2 in dead bats found at a single roost site in the UK. Arch Virol 2009; 154:1847-50. [PMID: 19841859 PMCID: PMC7086654 DOI: 10.1007/s00705-009-0504-8] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2009] [Accepted: 09/07/2009] [Indexed: 02/01/2023]
Abstract
In August 2007, European bat lyssavirus type 2 (EBLV-2) was isolated from a Daubenton’s bat found at Stokesay Castle. In September 2008, another bat from the same vicinity of Stokesay Castle also tested positive for EBLV-2. This is the first occurrence of repeated detection of EBLV-2 from a single site. Here, we report the detection of low levels of viral RNA in various bat organs by qRT-PCR and detection of viral antigen by immunohistochemistry. We also report sequence data from both cases and compare data with those derived from other EBLV-2 isolations in the UK.
Collapse
|
10
|
Freuling C, Vos A, Johnson N, Kaipf I, Denzinger A, Neubert L, Mansfield K, Hicks D, Nuñez A, Tordo N, Rupprecht CE, Fooks AR, Müller T. Experimental infection of serotine bats (Eptesicus serotinus) with European bat lyssavirus type 1a. J Gen Virol 2009; 90:2493-2502. [PMID: 19515825 DOI: 10.1099/vir.0.011510-0] [Citation(s) in RCA: 58] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
Abstract
The serotine bat (Eptesicus serotinus) accounts for the vast majority of bat rabies cases in Europe and is considered the main reservoir for European bat lyssavirus type 1 (EBLV-1, genotype 5). However, so far the disease has not been investigated in its native host under experimental conditions. To assess viral virulence, dissemination and probable means of transmission, captive bats were infected experimentally with an EBLV-1a virus isolated from a naturally infected conspecific from Germany. Twenty-nine wild caught bats were divided into five groups and inoculated by intracranial (i.c.), intramuscular (i.m.) or subcutaneous (s.c.) injection or by intranasal (i.n.) inoculation to mimic the various potential routes of infection. One group of bats was maintained as uninfected controls. Mortality was highest in the i.c.-infected animals, followed by the s.c. and i.m. groups. Incubation periods varied from 7 to 26 days depending on the route of infection. Rabies did not develop in the i.n. group or in the negative-control group. None of the infected bats seroconverted. Viral antigen was detected in more than 50% of the taste buds of an i.c.-infected animal. Shedding of viable virus was measured by virus isolation in cell culture for one bat from the s.c. group at 13 and 14 days post-inoculation, i.e. 7 days before death. In conclusion, it is postulated that s.c. inoculation, in nature caused by bites, may be an efficient way of transmitting EBLV-1 among free-living serotine bats.
Collapse
Affiliation(s)
- C Freuling
- Institute for Epidemiology, WHO Collaborating Centre for Rabies Surveillance and Research, Friedrich-Loeffler-Institute, Federal Research Institute of Animal Health, Seestrasse 55, 16868 Wusterhausen, Germany
| | - A Vos
- IDT Biologika GmbH, Am Pharmapark, 06861 Dessau-Rosslau, Germany
| | - N Johnson
- Rabies and Wildlife Zoonoses Group, WHO Collaborating Centre for the Characterisation of Rabies and Rabies-Related Viruses, Veterinary Laboratories Agency - Weybridge, Woodham Lane, Addlestone, Surrey KT15 3NB, UK
| | - I Kaipf
- Animal Physiology, Institute of Neurobiology, Eberhard-Karls-University, Auf der Morgenstelle 28, 72076 Tübingen, Germany
| | - A Denzinger
- Animal Physiology, Institute of Neurobiology, Eberhard-Karls-University, Auf der Morgenstelle 28, 72076 Tübingen, Germany
| | - L Neubert
- IDT Biologika GmbH, Am Pharmapark, 06861 Dessau-Rosslau, Germany
| | - K Mansfield
- Rabies and Wildlife Zoonoses Group, WHO Collaborating Centre for the Characterisation of Rabies and Rabies-Related Viruses, Veterinary Laboratories Agency - Weybridge, Woodham Lane, Addlestone, Surrey KT15 3NB, UK
| | - D Hicks
- Rabies and Wildlife Zoonoses Group, WHO Collaborating Centre for the Characterisation of Rabies and Rabies-Related Viruses, Veterinary Laboratories Agency - Weybridge, Woodham Lane, Addlestone, Surrey KT15 3NB, UK
| | - A Nuñez
- Rabies and Wildlife Zoonoses Group, WHO Collaborating Centre for the Characterisation of Rabies and Rabies-Related Viruses, Veterinary Laboratories Agency - Weybridge, Woodham Lane, Addlestone, Surrey KT15 3NB, UK
| | - N Tordo
- Institut Pasteur, Department of Virology, Antiviral Strategy Unit, 25-28 rue du Docteur Roux, 75724 Paris, France
| | - C E Rupprecht
- Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA
| | - A R Fooks
- Rabies and Wildlife Zoonoses Group, WHO Collaborating Centre for the Characterisation of Rabies and Rabies-Related Viruses, Veterinary Laboratories Agency - Weybridge, Woodham Lane, Addlestone, Surrey KT15 3NB, UK
| | - T Müller
- Institute for Epidemiology, WHO Collaborating Centre for Rabies Surveillance and Research, Friedrich-Loeffler-Institute, Federal Research Institute of Animal Health, Seestrasse 55, 16868 Wusterhausen, Germany
| |
Collapse
|